A study of the cell surface of tumour, foetal and lymph-node cells by cell electrophoresis after antibody and enzymic treatment.
1. Rabbit anti-(rat foetal liver) serum, absorbed with adult rat liver cells, decreased the electrophoretic mobility of foetal liver cells by 51% and rat hepatoma cells by 45%, indicating the presence of a foetal-type antigen on the hepatoma cell membrane. 2. The chemical nature of the surface antigen was investigated. Incubation with neuraminidase had no effect on adult liver cells but decreased the electrophoretic mobility of foetal liver cells by 51% and of hepatoma cells by 34%; the effect of antiserum was decreased to one-fifth. 3. Sialic acid, or the supernatant from neuraminidase-treated cells, partially blocked the decrease in electrophoretic mobility induced by antiserum. 4. The pH-electrophoretic mobility curves of hepatoma cells treated with antisera were consistent with a sialic acidcontaining antigen on the surface of the tumour cells. 5. Treatment with ribonuclease did not decrease the electrophoretic mobility of adult-liver cells, but decreased that of the foetal liver cells by 17% and hepatoma cells by 29%. 6. In parallel studies made with mouse BP8 ascites-tumour cells ribonuclease decreased the electrophoretic mobility by 39%, that of normal mouse lymph-node cells by 4.8% and allergized mouse lymph-node cells by 13.3%. 7. Trypsin treatment also decreased the electrophoretic mobility of hepatoma cells by 22%.
D000818:Animals; D000941:Antigens; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D003165:Complement System Proteins; D003584:Cytological Techniques; D004586:Electrophoresis; D005260:Female; D005333:Fetus / Q000201:enzymology / Q000276:immunology*; D007106:Immune Sera; D007075:Immunoglobulin M; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology / Q000276:immunology*; D008113:Liver Neoplasms / Q000201:enzymology / Q000276:immunology*; D008198:Lymph Nodes / Q000201:enzymology / Q000276:immunology*; D009438:Neuraminic Acids; D009439:Neuraminidase / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D051381:Rats; D012260:Ribonucleases / Q000494:pharmacology; D013499:Surface Properties; D014357:Trypsin / Q000494:pharmacology
D000941:Antigens; D007106:Immune Sera; D007075:Immunoglobulin M; D009438:Neuraminic Acids; D003165:Complement System Proteins; D012260:Ribonucleases; D009439:Neuraminidase; D014357:Trypsin